Alarico Ariani
Alarico Ariani publishes mostly in Rheumatology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, on topics such as Systemic Sclerosis and Related Diseases, Rheumatoid Arthritis Research and Therapies and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis.
- World rank
- #1,696,732 of 7,710,434 ranked researchers
- Rank in Italy
- #55,510 of 242,206
- Works
- 127
- Citations
- 1.4k
- Citations per work
- 11.2
What does Alarico Ariani research?
Alarico Ariani's work is mostly in Medicine (60%), Immunology and Microbiology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences7760.5%
- Medicine7760.5%
- Everything else4132.0%
- Life Sciences107.5%
- 1Rheumatology20% of their works
- 2Pathology and Forensic Medicine16% of their works
- 3Pulmonary and Respiratory Medicine14% of their works
- 4Immunology8% of their works
- 5Epidemiology5% of their works
- 6Radiology, Nuclear Medicine and Imaging4% of their works
Research topics
- Systemic Sclerosis and Related Diseases
- Rheumatoid Arthritis Research and Therapies
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Spondyloarthritis Studies and Treatments
- Inflammatory Myopathies and Dermatomyositis
- Psoriasis: Treatment and Pathogenesis
- Medical Imaging and Pathology Studies
- Biosimilars and Bioanalytical Methods
Which keywords describe Alarico Ariani's research?
The keywords of their largest research topics: Autoantibodies, Fibrosis, Treatment, Pulmonary Involvement, Systemic Sclerosis, Inflammation, Rheumatoid Arthritis and Interstitial Lung Disease.
- Biosimilars
- Pulmonary Sclerosing Hemangioma
- IL-17
- Dermatomyositis
- Ankylosing Spondylitis
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
- Inflammation
- Pulmonary Involvement
- Fibrosis
- Autoantibodies
- Treatment
- Systemic Sclerosis
- Rheumatoid Arthritis
- TGF-ß
- Myofibroblast
- Spondyloarthritis
- Inflammatory Myopathies
- Pulmonary Alveolar Microlithiasis
- TH17 Cells
- Immunogenicity
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Autoantibodies1113 topics
- Fibrosis792 topics
- Treatment682 topics
- Pulmonary Involvement531 topic
- Systemic Sclerosis531 topic
- Inflammation431 topic
- Rheumatoid Arthritis431 topic
- Interstitial Lung Disease412 topics
- TGF-ß392 topics
- Idiopathic Pulmonary Fibrosis261 topic
- Myofibroblast261 topic
- Ankylosing Spondylitis221 topic
- Spondyloarthritis221 topic
- Dermatomyositis151 topic
- Inflammatory Myopathies151 topic
- IL-17131 topic
- Pulmonary Alveolar Microlithiasis131 topic
- Pulmonary Sclerosing Hemangioma131 topic
- TH17 Cells131 topic
- Biosimilars101 topic
- Immunogenicity101 topic
Where does Alarico Ariani work?
Alarico Ariani's main affiliation in the publication record is Ospedale di Parma, Italy.
How many publications and citations does Alarico Ariani have?
OpenAlex counts 127 works and 1,417 citations for Alarico Ariani, an h-index of 20, ranking #1,696,732 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Alarico Ariani. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.